Clinical Trial Results:
            "Estudio de fase 4, doble ciego, controlado con placebo, multicéntrico y de  12 semanas de duración para evaluar la seguridad y la eficacia del tartrato de Vareniclina (CP-526,555) 1 mg dos veces al día para dejar de fumar en pacientes con depresión"
"A PHASE 4 12-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY EVALUATING THE SAFETY AND EFFICACY OF VARENICLINE TARTRATE (CP-526,555) 1MG BID FOR SMOKING CESSATION IN SUBJECTS WITH DEPRESSION"
    
|     Summary | |
|     EudraCT number | 2009-014916-37 | 
|     Trial protocol | ES DE HU | 
|     Global completion date | 
                                    13 Jun 2012
                             | 
|     Paediatric regulatory details | |
|     Is the trial part of an agreed EMA paediatric investigation plan? | 
                                        No
                                 | 
|     Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | 
                                        No
                                 | 
|     Results information | |
|     Results version number | v1(current) | 
|     This version publication date | 
                                    27 Apr 2016
                             | 
|     First version publication date | 
                                    12 Feb 2015
                             | 
|     Other versions | |
|     Summary report(s) | A3051122_Public Disclosure Synopsis | 
            Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to            Commission Guideline 2012/C 302/03
            for further information.    
 
				
